Clinical Trial Update: Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing safety and efficacy of a labeled versus wait-extend regimen of Lucentis in Turkish patients with vision impairment due to diabetic mac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2019-06-24